# Tranexamic Acid

## Transamin inj 250mg/5mL

| TAH Drug Code      | [ITRAN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ITRAN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Purpura， leukemia， hemoptysis and bloody sputum in pulmonary tuberculosis， abnormal bleeding during surgery， renal hemorrhage.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Adult: 250-500mg divide 1-2 times， IV/IM.During or after surgery: 500-1000 mg IV or 500-2500 mg by IV infusion.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Patients receiving thrombin therapy. Women using hormonal contraception with oral administration. Hypersensitivity to tranexamic acid [18][51] or any of the ingredients. Active intravascular clotting with IV administration. Subarachnoid hemorrhage; cerebral edema or infarction may occur with IV administration. Active thromboembolic disease (eg， DVT， pulmonary embolism， or cerebral thrombosis) with oral administration. History of thrombosis or thromboembolism， including retinal vein or artery occlusion with oral administration. Intrinsic risk of thrombosis or thromboembolism (eg， thrombogenic valvular disease， thrombogenic cardiac rhythm disease， or hypercoagulopathy) with oral administration. |
| Adverse Effects    | GI disturbances. Gastrointestinal: Abdominal pain (oral， 19.8% ) Hematologic: Anemia (oral， 5.6% ) Musculoskeletal: Arthralgia (oral， 6.9% )， Backache (oral， 20.7% )， Cramp (oral， 6.5% )， Musculoskeletal pain (oral， 11.2% ) Neurologic: Headache (oral， 50.4% )， Migraine (oral， 6% ) Respiratory: Nasal sinus problem (oral， 25.4% ) Other: Fatigue (oral， 5.2% )                                                                                                                                                                                                                                                                                                                                                 |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tranexamic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

## Transamin 250mg

| TAH Drug Code      | [OTRA2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTRA2)                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Systemic and localized bleeding or hemorrhagic disorders.                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | 750-2000 mg/day divide 3-4 times a day.                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Subarachnoid hemorrhage; cerebral edema or infarction may occur with IV administration. Active thromboembolic disease (eg， DVT， pulmonary embolism， or cerebral thrombosis) with oral administration. History of thrombosis or thromboembolism， including retinal vein or artery occlusion with oral administration. Intrinsic risk of thrombosis or thromboembolism (eg， thrombogenic valvular disease， thrombogenic cardiac rhythm disease， or hypercoagulopathy) with oral administration. |
| Adverse Effects    | GI disturbances. Gastrointestinal: Abdominal pain (oral， 19.8% ) Hematologic: Anemia (oral， 5.6% ) Musculoskeletal: Arthralgia (oral， 6.9% )， Backache (oral， 20.7% )， Cramp (oral， 6.5% )， Musculoskeletal pain (oral， 11.2% ) Neurologic: Headache (oral， 50.4% )， Migraine (oral， 6% ) Respiratory: Nasal sinus problem (oral， 25.4% ) Other: Fatigue (oral， 5.2% )                                                                                                                 |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tranexamic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                       |

